nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A09 A data coordinating center model for expanded access clinical trials
|
Yucaitis, Joy |
|
1993 |
14 |
5 |
p. 402- 1 p. |
artikel |
2 |
A26 A functional paradigm for clinical trial design
|
Greenfield, Mary Lou |
|
1993 |
14 |
5 |
p. 409- 1 p. |
artikel |
3 |
A65 A methodology to perform the “paperless” clinical trial: Electronic signatures for electronic data
|
Bailey, Lance R. |
|
1993 |
14 |
5 |
p. 425-426 2 p. |
artikel |
4 |
A64 A methodology to perform the “paperless” clinical trial: Overview and general principles
|
Rochon, James |
|
1993 |
14 |
5 |
p. 425- 1 p. |
artikel |
5 |
A36 Analysis of long term adverse experience data using the Weibull model
|
Shapiro, Deborah R. |
|
1993 |
14 |
5 |
p. 413- 1 p. |
artikel |
6 |
A16 An assessment of the value of double data entry and interactive checking
|
Fabri, Jackie |
|
1993 |
14 |
5 |
p. 405- 1 p. |
artikel |
7 |
A66 An integrated clinical trial database integrity evaluation system (DIES)
|
Levinson, Mark A. |
|
1993 |
14 |
5 |
p. 426- 1 p. |
artikel |
8 |
A18 A simulation study of the number of events per variable recommended in multivariable regression analyses
|
Peduzzi, Peter |
|
1993 |
14 |
5 |
p. 406- 1 p. |
artikel |
9 |
A17 A statistical design for multivariate study end-points
|
Luo, X. |
|
1993 |
14 |
5 |
p. 406- 1 p. |
artikel |
10 |
A13 Automated data entry using fax with optical character recognition
|
Achtenberg, Joel |
|
1993 |
14 |
5 |
p. 404- 1 p. |
artikel |
11 |
A48 Balancing treatment assignments in trials with large number of centers
|
Colopy, Mike |
|
1993 |
14 |
5 |
p. 418- 1 p. |
artikel |
12 |
A27 Beta errors revisited
|
Moher, D. |
|
1993 |
14 |
5 |
p. 410- 1 p. |
artikel |
13 |
A06 Changing the study design during the recruitment phase of an international perinatal multicentre clinical trial
|
Weston, Julie |
|
1993 |
14 |
5 |
p. 401- 1 p. |
artikel |
14 |
A19 Classification and regression trees as a tool to identify prognostic factors in long-term clinical trials
|
Hasford, J. |
|
1993 |
14 |
5 |
p. 406-407 2 p. |
artikel |
15 |
A63 Collection of electronic clinical data from UK community doctors
|
Bourke, Alison |
|
1993 |
14 |
5 |
p. 425- 1 p. |
artikel |
16 |
A35 Comparison of analytical methods when response fluctuates between success and failure
|
Linton, Kathryn L.P. |
|
1993 |
14 |
5 |
p. 413- 1 p. |
artikel |
17 |
A30 Computerized and centralized participant entry in large-scale, multi-centered clinical trials
|
Cronin, Walter M. |
|
1993 |
14 |
5 |
p. 411- 1 p. |
artikel |
18 |
A02 Confidence intervals for power probabilities: How powerful was that hypothesis test?
|
O'Brien, Ralph G. |
|
1993 |
14 |
5 |
p. 399- 1 p. |
artikel |
19 |
A38 Confidence intervals for the median survival time adjusted for covariates
|
Karrison, Theodore |
|
1993 |
14 |
5 |
p. 414- 1 p. |
artikel |
20 |
A25 Cooperative clinical trials in health services research in the department of veterans affairs
|
Henderson, William G. |
|
1993 |
14 |
5 |
p. 409- 1 p. |
artikel |
21 |
A07 Data management workload assessment for medical oncology
|
Trochanowski, B. |
|
1993 |
14 |
5 |
p. 401-402 2 p. |
artikel |
22 |
A15 Data quality assurance in a distributed data entry environment: An alternative to 100% keystroke verification
|
Clayton, K.J. |
|
1993 |
14 |
5 |
p. 405- 1 p. |
artikel |
23 |
A24 Design considerations in community based randomized trials
|
Gordon, Mae E. |
|
1993 |
14 |
5 |
p. 408-409 2 p. |
artikel |
24 |
A50 Development of a new instrument: Quality of life in epilepsy (QOLIE)
|
Creamer, Joyce |
|
1993 |
14 |
5 |
p. 419- 1 p. |
artikel |
25 |
A59 Development of a software using a touch tone phone system and a vocal interface for automatic registration and randomization in multicenter clinical trials: Further experience of the European lung cancer working party
|
Paesmans, M. |
|
1993 |
14 |
5 |
p. 423- 1 p. |
artikel |
26 |
A54 Does a placebo run-in identify poor adherers?: An empirical evaluation in the cholesterol reduction in seniors
|
Davis, C.E. |
|
1993 |
14 |
5 |
p. 421- 1 p. |
artikel |
27 |
A22 Drug development issues in the pacific region: Cost-effectiveness
|
Defina, John A. |
|
1993 |
14 |
5 |
p. 407-408 2 p. |
artikel |
28 |
A23 Economic implications of results from a clinical trial
|
Fink, Nancy |
|
1993 |
14 |
5 |
p. 408- 1 p. |
artikel |
29 |
A60 Ethics and statistical methodology in clinical trials
|
Palmer, Christopher R. |
|
1993 |
14 |
5 |
p. 423- 1 p. |
artikel |
30 |
A04 Evaluating noninvasive monitoring outside the intensive care unit: A method to enhance the before-after trial
|
Inman, K.J. |
|
1993 |
14 |
5 |
p. 400- 1 p. |
artikel |
31 |
A37 Exact logistic regression for small-sample clustered binary data
|
Mehta, Cyrus R. |
|
1993 |
14 |
5 |
p. 414- 1 p. |
artikel |
32 |
A34 Factor analytic strategies for evaluating generalizability of construct validity
|
Cornell, John E. |
|
1993 |
14 |
5 |
p. 413- 1 p. |
artikel |
33 |
A53 Factors predicting employment and job satisfaction in patients with severe left ventricular dysfunction
|
Ahn, Sylvie |
|
1993 |
14 |
5 |
p. 420- 1 p. |
artikel |
34 |
A57 Further experience with a 24-hour-a-day computerized randomization service
|
Weston, Julie |
|
1993 |
14 |
5 |
p. 422- 1 p. |
artikel |
35 |
A33 Identifying successful recruitment strategies in the lipid trial
|
Hague, W. |
|
1993 |
14 |
5 |
p. 412- 1 p. |
artikel |
36 |
A45 Interim analysis methods in the colon cancer control study
|
Church, Timothy |
|
1993 |
14 |
5 |
p. 417- 1 p. |
artikel |
37 |
A14 Lack of added-value from double data entry
|
Day, Simon |
|
1993 |
14 |
5 |
p. 404-405 2 p. |
artikel |
38 |
A41 Logistics of closeout in the asymptomatic carotid artery plaque study (ACAPS)
|
Margitić, Susan E. |
|
1993 |
14 |
5 |
p. 415- 1 p. |
artikel |
39 |
A43 Long-term survival follow-up in international clinical trials
|
Haugh, Margaret C. |
|
1993 |
14 |
5 |
p. 416- 1 p. |
artikel |
40 |
A58 Maintaining the integrity of a long-term randomized controlled trial using school districts as the unit of randomization
|
Mann, Sue |
|
1993 |
14 |
5 |
p. 422-423 2 p. |
artikel |
41 |
A46 On closed test procedures for dose response analysis
|
Rom, Dror M. |
|
1993 |
14 |
5 |
p. 417- 1 p. |
artikel |
42 |
A29 Optimizing patient selection in therapeutic experiments
|
Moons, K.G.M. |
|
1993 |
14 |
5 |
p. 410-411 2 p. |
artikel |
43 |
A01 Power analysis of cutoff-based randomized clinical trials
|
C. Cappelleri, Joseph |
|
1993 |
14 |
5 |
p. 399- 1 p. |
artikel |
44 |
A03 Powerspending in clinical trials using alpha-spending stopping rules
|
van Rossum, Jim |
|
1993 |
14 |
5 |
p. 400- 1 p. |
artikel |
45 |
A21 Principles of agreement for post NDA clinical trials
|
Holbrook, Janet T. |
|
1993 |
14 |
5 |
p. 407- 1 p. |
artikel |
46 |
A56 Randomization and treatment assignment in the CPCRA
|
Connett, John |
|
1993 |
14 |
5 |
p. 422- 1 p. |
artikel |
47 |
A55 Randomization in the APOLO study: A necessary compromise between the study design and practical constraints
|
Boissel, Jean-Pierre |
|
1993 |
14 |
5 |
p. 421- 1 p. |
artikel |
48 |
A44 Reducing patient withdrawals in a large multi-center clinical trial
|
Lee, Jennifer |
|
1993 |
14 |
5 |
p. 416-417 2 p. |
artikel |
49 |
A49 Reporting of allocation methods in clinical trials
|
Williams, Diane H. |
|
1993 |
14 |
5 |
p. 418-419 2 p. |
artikel |
50 |
A31 Representation of women and minorities in published clinical trials
|
Duffy, Barbara A. |
|
1993 |
14 |
5 |
p. 411- 1 p. |
artikel |
51 |
A61 Sample size and monitoring criteria for Bayesian phase II clinical trials
|
Thall, Peter F. |
|
1993 |
14 |
5 |
p. 424- 1 p. |
artikel |
52 |
A62 Sample size re-estimation in response to treatment noncompliance
|
Cosmatos, Dennis |
|
1993 |
14 |
5 |
p. 424- 1 p. |
artikel |
53 |
A08 Self-administered quality of life forms: Experience from the post coronary artery bypass graft studies
|
Fox, Norma Lynn |
|
1993 |
14 |
5 |
p. 402- 1 p. |
artikel |
54 |
A28 Should there be restrictions on indicator lesions for phase II trials in oncology?
|
Franklin, Hilary |
|
1993 |
14 |
5 |
p. 410- 1 p. |
artikel |
55 |
A32 Simultaneous patient enrollment in multiple randomized trials: Experience in GUSTO
|
Granger, Christopher |
|
1993 |
14 |
5 |
p. 412- 1 p. |
artikel |
56 |
A47 Statistical treatment comparisons for a trial of thrombolytic therapy in acute myocardial infarction
|
Lee, Kerry L. |
|
1993 |
14 |
5 |
p. 418- 1 p. |
artikel |
57 |
A51 The clinical and economic impact of clozapine treatment of refractory schizophrenia
|
Rosenheck, Robert |
|
1993 |
14 |
5 |
p. 419- 1 p. |
artikel |
58 |
A39 The GUSTO large trial experience with designing inservice materials
|
Huffman, Caroline M. |
|
1993 |
14 |
5 |
p. 414-415 2 p. |
artikel |
59 |
A42 The publications and presentations committee: What makes it work?
|
Margitić, Susan E. |
|
1993 |
14 |
5 |
p. 416- 1 p. |
artikel |
60 |
A40 The use of a non-compliance index to predict the feasibility of clinical trials
|
De Rosa, M. |
|
1993 |
14 |
5 |
p. 415- 1 p. |
artikel |
61 |
A52 The use of echocardiography in multicenter trials: Experience from the treatment of mild hypertension study (TOMHS)
|
Granditis, Greg A. |
|
1993 |
14 |
5 |
p. 420- 1 p. |
artikel |
62 |
A05 Use of a sequential method for monitoring safety in patients enrolled in the multicenter acute stroke trial
|
Boutitie, F. |
|
1993 |
14 |
5 |
p. 401- 1 p. |
artikel |
63 |
A20 Validation of surrogate outcomes for evaluation of cancer screening intervention
|
Barlow, William E. |
|
1993 |
14 |
5 |
p. 407- 1 p. |
artikel |
64 |
Design and methods of a clinical trial for a rare condition: The collaborative ocular melanoma study
|
|
|
1993 |
14 |
5 |
p. 362-391 30 p. |
artikel |
65 |
Fifteenth annual meeting of the society for clinical trials
|
|
|
1993 |
14 |
5 |
p. 392- 1 p. |
artikel |
66 |
P76 A computerized drug distribution system for a multicenter, international clinical trial
|
Christopher, Donna L. |
|
1993 |
14 |
5 |
p. 459- 1 p. |
artikel |
67 |
P10 A computerized network system for the management of a large scale multicentre clinical trial: The GISSI-3 trial
|
Santoro, Eugenio |
|
1993 |
14 |
5 |
p. 430- 1 p. |
artikel |
68 |
P52 A computerized patient-donor tracking system to facilitate marrow transplants
|
Randall, Bryan L. |
|
1993 |
14 |
5 |
p. 448-449 2 p. |
artikel |
69 |
P71 Adverse event reporting in an AIDS trial
|
Isaacson, Milana |
|
1993 |
14 |
5 |
p. 457- 1 p. |
artikel |
70 |
P89 A generalized log-logistic model for analysis of interval-censored failure time data
|
Singh, Karan P. |
|
1993 |
14 |
5 |
p. 465- 1 p. |
artikel |
71 |
P39 A meta-analysis in preventing restenosis after percutaneous transluminal coronary angioplasty
|
Huang, David C. |
|
1993 |
14 |
5 |
p. 443- 1 p. |
artikel |
72 |
P48 Analysis of ratios: A case study based on arterial distensibility
|
Evans, G.W. |
|
1993 |
14 |
5 |
p. 447- 1 p. |
artikel |
73 |
P61 An automated telephone response system
|
Pollizzi, S. |
|
1993 |
14 |
5 |
p. 452- 1 p. |
artikel |
74 |
P59 A quality assurance program in cancer clinical trials
|
Niland, Joyce |
|
1993 |
14 |
5 |
p. 451-452 2 p. |
artikel |
75 |
P51 Archiving and material storage for a long-term clinical trial
|
Coates, Townes C. |
|
1993 |
14 |
5 |
p. 448- 1 p. |
artikel |
76 |
P53 A self-report design promoting the validity and re retrieval rate outcome measures in a controlled trial of dichlorphenamide in periodic paralysis
|
Herr, Barbara |
|
1993 |
14 |
5 |
p. 449- 1 p. |
artikel |
77 |
P49 A simple trial?
|
Jevons, Caroline M. |
|
1993 |
14 |
5 |
p. 447- 1 p. |
artikel |
78 |
P57 BMDPLOT: Publication-quality survival plots from BMDP output
|
Corley, S. |
|
1993 |
14 |
5 |
p. 451- 1 p. |
artikel |
79 |
P13 Centralized control of an automated telephone response system
|
Mirenzi, Evelyn |
|
1993 |
14 |
5 |
p. 432- 1 p. |
artikel |
80 |
P43 Clinical panel assessment of photodamaged skin treated with isotretinoin using photographs
|
Armstrong, Robert B. |
|
1993 |
14 |
5 |
p. 445- 1 p. |
artikel |
81 |
P58 Cluster sampling to estimate key entry error rates
|
Pearce, Lesly A. |
|
1993 |
14 |
5 |
p. 451- 1 p. |
artikel |
82 |
P32 Collecting quality of life (QOL) information: Does it facilitate or impede physician accrual of eligible patients to randomized cancer trials?
|
Taylor, Kathryn M. |
|
1993 |
14 |
5 |
p. 440- 1 p. |
artikel |
83 |
P75 Complexities of altering the study design of a large clinical trial in progress without interrupting enrollment
|
Christopher, Donna L. |
|
1993 |
14 |
5 |
p. 458-459 2 p. |
artikel |
84 |
P14 Computer generated electronic mail in clinical trials
|
Turner, Martha W. |
|
1993 |
14 |
5 |
p. 432- 1 p. |
artikel |
85 |
P65 Considerations for a group sequential, dose-response trial design
|
Anderson, Keaven M. |
|
1993 |
14 |
5 |
p. 454- 1 p. |
artikel |
86 |
P68 Constructing confidence intervals about multiple indices of effect size
|
Borenstein, Michael |
|
1993 |
14 |
5 |
p. 455- 1 p. |
artikel |
87 |
P77 Coordinating drug distribution for a large clinical trial
|
Christopher, Donna L. |
|
1993 |
14 |
5 |
p. 459- 1 p. |
artikel |
88 |
P87 Coping with the fast change of medical technology in clinical trials
|
Binkowitz, Bruce S. |
|
1993 |
14 |
5 |
p. 464- 1 p. |
artikel |
89 |
P85 Cox regression versus discriminant techniques: Can we predict a high risk group in stage I epithelial ovarian cancer?
|
Dunn, Janet A. |
|
1993 |
14 |
5 |
p. 463- 1 p. |
artikel |
90 |
P03 Creating archival tapes for sharing final study data
|
Raiz, Pauline |
|
1993 |
14 |
5 |
p. 427- 1 p. |
artikel |
91 |
P09 Database management of national cancer institute-sponsored cancer treatment trials
|
Phillips, Pamela H. |
|
1993 |
14 |
5 |
p. 430- 1 p. |
artikel |
92 |
P27 Data monitoring issues in cancer screening trials
|
Wells, Barbara L. |
|
1993 |
14 |
5 |
p. 438- 1 p. |
artikel |
93 |
P55 Designing a registration system for the clinical research database system
|
Pan, Q. |
|
1993 |
14 |
5 |
p. 450- 1 p. |
artikel |
94 |
P63 Design of a randomized trial of combined nucleoside analog antiretroviral therapy in AIDS patients
|
Church, Timothy |
|
1993 |
14 |
5 |
p. 453- 1 p. |
artikel |
95 |
P18 Development of a monitor driven clinical grant payment tracking and forecasting information system
|
Nonomura, John |
|
1993 |
14 |
5 |
p. 434- 1 p. |
artikel |
96 |
P47 Development of an historical control series in assessing treatment effect of instrumenting spine disorders
|
Carlow, John J. |
|
1993 |
14 |
5 |
p. 446- 1 p. |
artikel |
97 |
P88 Deviation of actual longitudinal data collection times from “ideal” times
|
Keller, Jean A. |
|
1993 |
14 |
5 |
p. 464-465 2 p. |
artikel |
98 |
P54 Educating data managers — What needs to be done?
|
Quinlivan, S. |
|
1993 |
14 |
5 |
p. 449-450 2 p. |
artikel |
99 |
P01 Educational activities of the Dutch working group for data managers
|
Boon, Mildred C. |
|
1993 |
14 |
5 |
p. 426- 1 p. |
artikel |
100 |
P19 Efficacy/compliance relationship in a large scale trial on hypertensive patients
|
Boissel, Jean-Pierre |
|
1993 |
14 |
5 |
p. 434- 1 p. |
artikel |
101 |
P82 Efficacy of double-blinding in a randomized controlled trial (RCT) of low dose warfarin to prevent thromboembolic disease in patients with metastatic breast cancer
|
Dickson, Lenore |
|
1993 |
14 |
5 |
p. 462- 1 p. |
artikel |
102 |
P41 Equivalence testing using available statistical software
|
Alvir, Jose Ma.J. |
|
1993 |
14 |
5 |
p. 444- 1 p. |
artikel |
103 |
P04 Establishment of an adverse event reporting (AER) database: The National Cancer Institute of Canada clinical trials group (NCIC CTG) experience
|
Muldal, A. |
|
1993 |
14 |
5 |
p. 428- 1 p. |
artikel |
104 |
P86 Evaluating the strength of prognostic factors in a series of 1400 patients with myelomatosis
|
Dunn, Janet A. |
|
1993 |
14 |
5 |
p. 464- 1 p. |
artikel |
105 |
P02 Experience with geographically-distributed data entry in multi-center clinical trials
|
Gee, Lauren |
|
1993 |
14 |
5 |
p. 427- 1 p. |
artikel |
106 |
P66 Factors influencing women's clinical trial participation
|
Valanis, Barbara G. |
|
1993 |
14 |
5 |
p. 455- 1 p. |
artikel |
107 |
P79 Global coordination of a 41,000 patient international trial
|
Karnash, Sharon |
|
1993 |
14 |
5 |
p. 460-461 2 p. |
artikel |
108 |
P78 Hotline calls: A key to communication in a large trial
|
Davis, Catherine |
|
1993 |
14 |
5 |
p. 460- 1 p. |
artikel |
109 |
P26 Improving patient compliance
|
Baker, Patricia G. |
|
1993 |
14 |
5 |
p. 437- 1 p. |
artikel |
110 |
P64 Instrument development: Rolls-Royce versus Volkswagen
|
Rush, B. |
|
1993 |
14 |
5 |
p. 454- 1 p. |
artikel |
111 |
P60 Interfacing microsoft excel 4.0® and SAS® for report generation in clinical trials
|
Goodwin, Robert R. |
|
1993 |
14 |
5 |
p. 452- 1 p. |
artikel |
112 |
Plenary session III- Brother, can you sponsor a trial? The story of the survival and ventricular enlargement study (SAVE)
|
|
|
1993 |
14 |
5 |
p. 398- 1 p. |
artikel |
113 |
Plenary session II- Intention to treat — New issues
|
|
|
1993 |
14 |
5 |
p. 395- 1 p. |
artikel |
114 |
Plenary session I - Outcomes research —The role of randomized clinical trial
|
|
|
1993 |
14 |
5 |
p. 394- 1 p. |
artikel |
115 |
P22 Linking protocol to forms development through the use of a relational database in multi-disciplinary randomized clinical trials
|
Edwards, Carol |
|
1993 |
14 |
5 |
p. 435-436 2 p. |
artikel |
116 |
P34 Methods of outcome assessment in National Eye Institute sponsored multicenter clinical trials
|
McCaffrey, Lee |
|
1993 |
14 |
5 |
p. 441- 1 p. |
artikel |
117 |
P38 Methods of school-based data collection in longitudinal prevention trials
|
Renshaw-Myrwang, Renée |
|
1993 |
14 |
5 |
p. 443- 1 p. |
artikel |
118 |
P45 Modeling the time dependency of circulating microbubbles on symptoms of decompression sickness for space extravehicular activities
|
Kumar, K.Vasantha |
|
1993 |
14 |
5 |
p. 445-446 2 p. |
artikel |
119 |
P07 Monitoring completion of data form discrepancies
|
Pelusio, Rita M. |
|
1993 |
14 |
5 |
p. 429- 1 p. |
artikel |
120 |
P20 Monitoring safety in a multi-center clinical trial of acute ischemic stroke
|
Clarke, William R. |
|
1993 |
14 |
5 |
p. 435- 1 p. |
artikel |
121 |
P81 No more lost to follow-up! insuring complete patient tracking post hospital discharge: The caveat coordinating center experience
|
Berdan, Lisa G. |
|
1993 |
14 |
5 |
p. 461-462 2 p. |
artikel |
122 |
P25 Outcome assessment in the treatment of acute low back pain
|
Malmivaara, Antti |
|
1993 |
14 |
5 |
p. 437- 1 p. |
artikel |
123 |
P12 Patient accrual: Past experience, future options
|
Ward, Linda |
|
1993 |
14 |
5 |
p. 431- 1 p. |
artikel |
124 |
P74 Personalizing a large trial: Every sites' contribution counts
|
Smith, Deborah D. |
|
1993 |
14 |
5 |
p. 458- 1 p. |
artikel |
125 |
P35 Phantom or real? Verification of nonrandomized patients evaluated for randomized clinical trials for a rare disease
|
Manos, Kelly S. |
|
1993 |
14 |
5 |
p. 441- 1 p. |
artikel |
126 |
P15 Phase IV clinical trials: The good, the bad, and the ugly
|
Decoster, Genevieve |
|
1993 |
14 |
5 |
p. 432-433 2 p. |
artikel |
127 |
P05 Phases of data form design for the obstetrical triage study
|
Meininger, Elise |
|
1993 |
14 |
5 |
p. 428- 1 p. |
artikel |
128 |
P90 Pooling data from five stroke prevention clinical trials versus performing a meta-analysis
|
Fletcher, K.A. |
|
1993 |
14 |
5 |
p. 465- 1 p. |
artikel |
129 |
P62 Preditor: An organized and efficient approach for ensuring data quality in a clinical trial
|
Martin, Jeffrey |
|
1993 |
14 |
5 |
p. 453- 1 p. |
artikel |
130 |
P50 Project control of software applications
|
Karabelas, Susan |
|
1993 |
14 |
5 |
p. 448- 1 p. |
artikel |
131 |
P28 Promoting enrollment in a multi-center clinical trial
|
Rudolph, Alice |
|
1993 |
14 |
5 |
p. 438- 1 p. |
artikel |
132 |
P08 Providing stable data structures for interim analysis of a growing database
|
Eng, Heather |
|
1993 |
14 |
5 |
p. 429- 1 p. |
artikel |
133 |
Preconference workshop 2 overview of good clinical practices! FDA Audits — How to avoid the common pitfalls
|
|
|
1993 |
14 |
5 |
p. 393- 1 p. |
artikel |
134 |
Preconference workshop 1 the development and evolution of funded clinical trial initiatives
|
|
|
1993 |
14 |
5 |
p. 393- 1 p. |
artikel |
135 |
P29 Recruitment of breast cancer patients to clinical trials: General issues and barriers
|
Siminoff, Laura A. |
|
1993 |
14 |
5 |
p. 438-439 2 p. |
artikel |
136 |
P33 Recruitment strategies in rheumatoid arthritis (RA) clinical trials (CT): The mira experience
|
Tilley, Barbara C. |
|
1993 |
14 |
5 |
p. 440- 1 p. |
artikel |
137 |
P36 Responses to ethical and other questions on a knowledge assessment form for a multicenter trial
|
Scherer, R. |
|
1993 |
14 |
5 |
p. 442- 1 p. |
artikel |
138 |
P24 Role of site and central laboratories in multi-center clinical trials: An illustration from a VA cooperative infectious disease trial
|
Voynick, Irene M. |
|
1993 |
14 |
5 |
p. 436- 1 p. |
artikel |
139 |
P31 Salvaging clinical trials forced to terminate early by results of external information
|
Zee, B. |
|
1993 |
14 |
5 |
p. 439-440 2 p. |
artikel |
140 |
P21 Selecting and monitoring alert levels — What are the issues?
|
Wasilauskas, Carol H. |
|
1993 |
14 |
5 |
p. 435- 1 p. |
artikel |
141 |
P30 Selection of quality of life instruments for the MDRD study and results of baseline analyses
|
Gassman, Jennifer |
|
1993 |
14 |
5 |
p. 439- 1 p. |
artikel |
142 |
P67 Sensitivity of power computations for design considerations in clinical trials
|
Arena, Vincent C. |
|
1993 |
14 |
5 |
p. 455- 1 p. |
artikel |
143 |
P23 Shift tables for presentation of clinical data
|
Bristol, David R. |
|
1993 |
14 |
5 |
p. 436- 1 p. |
artikel |
144 |
P80 Source verification in large clinical trials: Is 10% enough?
|
Karnash, Sharon |
|
1993 |
14 |
5 |
p. 461- 1 p. |
artikel |
145 |
P70 Stage migration in a surgical trial
|
Bunt, A.M.G. |
|
1993 |
14 |
5 |
p. 456- 1 p. |
artikel |
146 |
P69 Standardization in a surgical trial
|
Bunt, A.M.G. |
|
1993 |
14 |
5 |
p. 456- 1 p. |
artikel |
147 |
P73 Standardizing documentation for trials
|
Van Natta, Mark |
|
1993 |
14 |
5 |
p. 457-458 2 p. |
artikel |
148 |
P37 Starting research in new areas: Health care directives in the institutionalized elderly
|
Urbanyi, Mafalda |
|
1993 |
14 |
5 |
p. 442- 1 p. |
artikel |
149 |
P84 Statistical analysis of coronary angiographic data: patients or lesions?
|
Mack, Wendy J. |
|
1993 |
14 |
5 |
p. 463- 1 p. |
artikel |
150 |
P44 Statistical issues in the design and analysis of clinical trials evaluating therapy for chronic asthma
|
Ji Zhang, |
|
1993 |
14 |
5 |
p. 445- 1 p. |
artikel |
151 |
P16 Statistical issues in the design of the trial of nonpharmacologic interventions in the elderly (tone)
|
Espeland, Mark |
|
1993 |
14 |
5 |
p. 433- 1 p. |
artikel |
152 |
P17 Summarizing carotid intimal-medial thickness in the asymptomatic carotid artery plaque study
|
Hoen, Helena |
|
1993 |
14 |
5 |
p. 433- 1 p. |
artikel |
153 |
P83 Survival analysis of 4-period, 4-treatment crossover design with repeated measures
|
Chao Wang, |
|
1993 |
14 |
5 |
p. 462- 1 p. |
artikel |
154 |
P11 System for monitoring timing of data review and entry
|
Zee, Benny |
|
1993 |
14 |
5 |
p. 431- 1 p. |
artikel |
155 |
P06 Taking control of your clinical trial: Remote database management (RDM)
|
Rushing, Scott |
|
1993 |
14 |
5 |
p. 428-429 2 p. |
artikel |
156 |
P42 The effect of drug exposure on incidence rates of adverse clinical events within antibiotic trials
|
Rutkiewicz, Victoria |
|
1993 |
14 |
5 |
p. 444-445 2 p. |
artikel |
157 |
P40 The identification of prognostic factors in breast cancer
|
Ulm, K. |
|
1993 |
14 |
5 |
p. 443-444 2 p. |
artikel |
158 |
P72 Therapy adherence and mortality in the cardiac arrhythmia suppression trial
|
Manno, Dulce Obias |
|
1993 |
14 |
5 |
p. 457- 1 p. |
artikel |
159 |
P46 Two randomized equivalence trials in pediatric oncology: Analysis of censored data
|
Com-Nougue, C. |
|
1993 |
14 |
5 |
p. 446- 1 p. |
artikel |
160 |
P56 Using data management statistics and system resources statistics for quality assurance
|
Remaley, Nancy H. |
|
1993 |
14 |
5 |
p. 450-451 2 p. |
artikel |
161 |
S11 Estimating the treatment effect on survival from right-censored data in a randomized clinical trial with non-random noncompliance
|
Hu, Fu-Chung |
|
1993 |
14 |
5 |
p. 403- 1 p. |
artikel |
162 |
S12 Lower confidence bounds for time to cure
|
Rabinowitz, Daniel |
|
1993 |
14 |
5 |
p. 404- 1 p. |
artikel |
163 |
S10 Planning of clinical trials using biomarkers as endpoints
|
Kirby, Alison J. |
|
1993 |
14 |
5 |
p. 403- 1 p. |
artikel |
164 |
Statistical considerations in monitoring the Systolic Hypertension in the Elderly Program (SHEP)
|
Davis, Barry R. |
|
1993 |
14 |
5 |
p. 350-361 12 p. |
artikel |
165 |
Suspended judgment from “tame” to “forbidden” death
|
Silverman, William A. |
|
1993 |
14 |
5 |
p. 347-349 3 p. |
artikel |
166 |
Workshop II- Data management issues related to preparation and release of study data
|
|
|
1993 |
14 |
5 |
p. 394- 1 p. |
artikel |
167 |
Workshop III- Consumers and their influence on the design and conduct of clinical trials
|
|
|
1993 |
14 |
5 |
p. 395- 1 p. |
artikel |
168 |
Workshop I- The use of health-related quality of life measures in cross national clinical trials. Issues and perspectives
|
|
|
1993 |
14 |
5 |
p. 394- 1 p. |
artikel |
169 |
Workshop IV- Partnership opportunities among academia, venture capitalists, contract research organizations, and industry
|
|
|
1993 |
14 |
5 |
p. 396- 1 p. |
artikel |
170 |
Workshop V- Adapting generic quality of life scales to specific populations
|
|
|
1993 |
14 |
5 |
p. 396- 1 p. |
artikel |
171 |
Workshop VIII- Recruitment issues in research: A focus on women and minorities
|
|
|
1993 |
14 |
5 |
p. 398- 1 p. |
artikel |
172 |
Workshop VII- Issues in analyzing disease progression using clinical classification systems
|
|
|
1993 |
14 |
5 |
p. 397- 1 p. |
artikel |
173 |
Workshop VI- New technologies in data capture
|
|
|
1993 |
14 |
5 |
p. 397- 1 p. |
artikel |